Using a convenient A-to-Z organization, Treatment of Skin Disease, 7th Edition, covers more than 260 of the dermatologic conditions you’re most likely to encounter. This award-winning, up-to-date text puts every possible therapeutic option at your disposal—including management strategies, first- to third-line therapies, and off-label uses—for a truly complete guide to the vast array of dermatologic treatment options. Summaries of each treatment strategy are accompanied by detailed discussions of treatment choices, with clear evidence levels ranging from double-blind randomised controlled trials to anecdotal reports.
Key Features
Presents information in a concise, consistent, tabular format, with checklists of diagnostic and investigative pearls, full-color clinical images, and color-coded boxes for quick reference
Includes new chapters on Cryoglobulinemia, Frontal fibrosing alopecia, Lipoedema, Lipoid proteinosis, mpox, and Stasis dermatitis/ID reaction
Provides first- to third-line therapies for 261 of the most common skin disorders, including specific drug doses
Discusses recently introduced drugs, including several new biologics for psoriasis, hidradenitis, and atopic dermatitis; other biologics in development for connective tissue disorders; new JAK inhibitors for a topic dermatitis, vitiligo, alopecia areata, and numerous other disorders; spesolimab for generalized pustular psoriasis; new lasers for various conditions, including pigmentary disorders; and more
Includes off-label uses, new treatments like monoclonal antibodies, and new indications for existing treatments
Offers the combined knowledge and expertise of the world’s leading authorities in dermatology, and is an ideal tool to assist with prior authorizations
AnBook version is included with purchase. The Book allows you to access all of the text, figures, and references, with the ability to search, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish after the publication date
Author Information
Mark Lebwohl,Chairman Emeritus Kimberly and Eric J. Waldman, Department of Dermatology, Dean for Clinical Therapeutics, Icahn School of Medicine, Mount Sinai, New York, NY, USA;Ian H. Coulson,Consultant Dermatologist, East Lancashire NHS Trust, Lancashire, UK;Dedee Murrell,Professor and Chair of Dermatology, Department of Dermatology, St. George Hospital and the George Institute for Global Health, University of New South Wales, Sydney, Australia;Antonella Tosti,Fredric Brandt Endowed Professor, Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami, Miami, FL, USA
